Perfil de la empresa · Healthcare

Bruker Corporation

BRKR · EE. UU.
Bolsa
EE. UU.
País / Región
USA
Fecha de salida a bolsa
4 de agosto de 2000
Empleados
11.085
Precio actual
$54.73
En vivo · 18 de junio de 2026
Compra razonable
≤ $48
Entrada con margen de seguridad
Puntuación de crecimiento Baillie
41/100
Floja
Valor intrínseco · Rango en tres niveles Precio actual $54.73 En vivo · Dentro del rango de valor intrínseco razonable

Rango de valoración compuesto · conservador $35–$45 / razonable $48–$60 / optimista $68–$85. A $54.73, Dentro del rango de valor intrínseco razonable.

Al publicar $59.97 (4 de junio de 2026)

Aún no hay análisis sobre este valor en tu idioma.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Capitalización8331,31 MUS$
Ingresos (TTM)3458,5 MUS$
EBITDA488,7 MUS$
Margen neto-0,34 %
ROE-0,43 %
PER previsto15,22
PEG1,52
BPA-0,24 US$
Rentabilidad por dividendo0,36 %
Rango de 52 semanas28,41 US$ – 64,54 US$
Precio objetivo de analistas53,25 US$
Recomendación de analistas3.9 / 5

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.